全球細胞膜穿透胜肽市場按類型、應用、最終用戶和地區分類

Global Cell Penetrating Peptide Market, By Type, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 179 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球細胞膜穿透胜肽市場規模為 42 億美元，到 2032 年將達到 121.6 億美元，2025 年至 2032 年的複合年成長率為 16.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	42億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	16.40%	2032年價值預測	121.6億美元

數字。 2025年全球市場佔有率（%）

細胞穿透胜肽（CPP）是一類短胺基酸序列，可穿過細胞膜並將抗體、核酸和化療藥物等生物活性劑輸送到細胞中。其跨越屏障的能力使其成為一種重要的分子轉運體，能夠輸送多種臨床實驗和核准的治療劑。在這個市場中，正在積極進行研究，最佳化細胞穿透胜肽（CPP）的序列和結合技術，以改善穩定性、溶解度和細胞吸收效率等藥理特性。隨著人們對開發基於 CPP 的癌症、神經退化和慢性感染疾病等疾病的市場策略的興趣日益濃厚，細胞穿透胜肽市場預計將在未來幾年快速成長。

CPPs 與傳統轉染方法相比具有許多優勢，因為它們可以在生理條件下非侵入性、高效、快速地將貨物分子輸送到活細胞中。由於其易於分子結合和高度生物相容性，CPP 在研究和治療應用方面具有巨大潛力，包括蛋白質治療、基因傳遞和診斷成像。然而，其非選擇性雙層破壞和高濃度下的潛在細胞毒性仍然是主要挑戰。改進的設計策略旨在開發更安全、更特異性的CPP。

市場動態：

細胞膜穿透胜肽市場的發展受到以下因素的推動：癌症等需要細胞內輸送治療劑的疾病數量的增加、研發的進步、製藥公司的投資以及胜肽類藥物的日益普及。然而，一些CPPs存在的穩定性差、毒性不可預測、免疫反應抑制等問題阻礙了市場的成長。正在進行的開發新一代無毒且高度生物相容性的胜肽序列的研究提供了巨大的商業機會。

本研究的主要特點

本報告對全球細胞膜穿透胜肽市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。
它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球細胞膜穿透胜肽市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球細胞膜穿透胜肽市場所使用的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.40%	2032 Value Projection:	USD 12.16 Bn

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Key features of the study:

This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

Global Cell Penetrating Peptide Market, By Type
- Protein Derived CPPs
- Synthetic CPPs
- Chimeric CPPs
Global Cell Penetrating Peptide Market, By Application
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Others
Global Cell Penetrating Peptide Market, By End User
- Biopharmaceutical Companies
- Contract Research Organization (CROs)/CDMO
- Hospitals and Clinics
- Others
Global Cell Penetrating Peptide Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- AnaSpec
- Peptomyc
- BioAlps
- Sarepta Therapeutics, Inc.
- REVANCE THERAPEUTICS
- PolyPeptide Group
- Bachem
- Pepscan
- Creative Peptides
- Cupidpeptides
- AltaBioscience Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Cell Penetrating Peptide Market, By Type
- Global Cell Penetrating Peptide Market, By Application
- Global Cell Penetrating Peptide Market, By End User
- Global Cell Penetrating Peptide Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Expanding Applications in Regenerative Medicine
- Low drug encapsulation efficiency
- Increasing applications of CPPs in therapeutics development
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Protein Derived CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Synthetic CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Chimeric CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Molecular Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organization (CROs)/CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

AnaSpec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Peptomyc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioAlps
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
REVANCE THERAPEUTICS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
Bachem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pepscan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Peptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cupidpeptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AltaBioscience Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views